Concepts (236)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Hantavirus | 5 | 2019 | 63 | 2.36 | Why? |
| Hantavirus Infections | 4 | 2018 | 62 | 1.48 | Why? |
| Mononegavirales | 2 | 2019 | 9 | 1.01 | Why? |
| Virology | 4 | 2019 | 489 | 0.81 | Why? |
| Phylogeny | 15 | 2021 | 13341 | 0.77 | Why? |
| Genome, Viral | 11 | 2021 | 13157 | 0.77 | Why? |
| Moles | 1 | 2018 | 4 | 0.74 | Why? |
| Arenaviridae | 1 | 2018 | 37 | 0.74 | Why? |
| Paramyxovirinae | 1 | 2018 | 49 | 0.74 | Why? |
| Hantavirus Pulmonary Syndrome | 1 | 2017 | 17 | 0.72 | Why? |
| Giraffes | 1 | 2016 | 1 | 0.70 | Why? |
| Deltapapillomavirus | 1 | 2016 | 1 | 0.70 | Why? |
| DNA, Circular | 1 | 2017 | 26 | 0.68 | Why? |
| Phylogeography | 1 | 2021 | 824 | 0.65 | Why? |
| Rodentia | 1 | 2018 | 235 | 0.65 | Why? |
| DNA Viruses | 1 | 2017 | 184 | 0.57 | Why? |
| Papillomaviridae | 1 | 2018 | 404 | 0.54 | Why? |
| Genomics | 4 | 2021 | 3118 | 0.52 | Why? |
| Cytomegalovirus | 1 | 2019 | 600 | 0.51 | Why? |
| Mesocricetus | 2 | 2021 | 1847 | 0.50 | Why? |
| Membrane Proteins | 3 | 2021 | 1733 | 0.48 | Why? |
| Drug Resistance, Viral | 1 | 2019 | 1083 | 0.47 | Why? |
| Papillomavirus Infections | 1 | 2016 | 861 | 0.35 | Why? |
| Sequence Analysis, DNA | 5 | 2018 | 2830 | 0.31 | Why? |
| Coronavirus OC43, Human | 4 | 2009 | 1157 | 0.31 | Why? |
| Viral Proteins | 3 | 2019 | 7370 | 0.30 | Why? |
| Disease Models, Animal | 5 | 2021 | 10998 | 0.30 | Why? |
| Nucleic Acid Amplification Techniques | 1 | 2017 | 3388 | 0.24 | Why? |
| Belgium | 4 | 2021 | 2064 | 0.22 | Why? |
| Evolution, Molecular | 5 | 2021 | 3691 | 0.22 | Why? |
| Cluster Analysis | 2 | 2019 | 3001 | 0.21 | Why? |
| Hydroxylamines | 1 | 2021 | 182 | 0.20 | Why? |
| Animals | 20 | 2021 | 78931 | 0.20 | Why? |
| STAT2 Transcription Factor | 1 | 2020 | 141 | 0.20 | Why? |
| Cytidine | 1 | 2021 | 219 | 0.20 | Why? |
| Genome Size | 1 | 2018 | 38 | 0.19 | Why? |
| Transplants | 1 | 2020 | 136 | 0.19 | Why? |
| Classification | 1 | 2019 | 55 | 0.19 | Why? |
| Paramyxoviridae | 1 | 2018 | 67 | 0.19 | Why? |
| Gene Order | 1 | 2018 | 144 | 0.18 | Why? |
| Nerve Tissue Proteins | 1 | 2021 | 319 | 0.18 | Why? |
| Arenaviridae Infections | 1 | 2018 | 43 | 0.18 | Why? |
| Likelihood Functions | 1 | 2021 | 719 | 0.18 | Why? |
| Puumala virus | 1 | 2017 | 11 | 0.18 | Why? |
| Respiratory System | 2 | 2021 | 3213 | 0.18 | Why? |
| Eukaryota | 1 | 2017 | 31 | 0.18 | Why? |
| Common Variable Immunodeficiency | 1 | 2020 | 195 | 0.18 | Why? |
| Sapovirus | 1 | 2017 | 20 | 0.18 | Why? |
| Genome, Human | 1 | 2021 | 400 | 0.17 | Why? |
| Sequence Homology | 1 | 2018 | 448 | 0.17 | Why? |
| Amino Acid Sequence | 2 | 2019 | 6049 | 0.17 | Why? |
| Cricetinae | 3 | 2021 | 3344 | 0.16 | Why? |
| Chloroquine | 2 | 2009 | 3152 | 0.16 | Why? |
| Encephalitis Viruses, Tick-Borne | 1 | 2016 | 100 | 0.15 | Why? |
| Nanopores | 1 | 2016 | 128 | 0.15 | Why? |
| Cyclophosphamide | 1 | 2017 | 387 | 0.15 | Why? |
| Encephalitis, Tick-Borne | 1 | 2016 | 86 | 0.15 | Why? |
| Lymphoma | 1 | 2020 | 522 | 0.15 | Why? |
| Biodiversity | 1 | 2019 | 546 | 0.14 | Why? |
| Immunization, Passive | 5 | 2022 | 10067 | 0.14 | Why? |
| Cloning, Molecular | 1 | 2018 | 1036 | 0.14 | Why? |
| Spatio-Temporal Analysis | 1 | 2021 | 1182 | 0.14 | Why? |
| Plasmids | 1 | 2018 | 840 | 0.14 | Why? |
| Mutation | 5 | 2021 | 12376 | 0.14 | Why? |
| Genetic Variation | 2 | 2019 | 3919 | 0.13 | Why? |
| Caliciviridae Infections | 1 | 2017 | 229 | 0.13 | Why? |
| Terminology as Topic | 1 | 2019 | 546 | 0.13 | Why? |
| Genome-Wide Association Study | 1 | 2021 | 1648 | 0.13 | Why? |
| Fecal Microbiota Transplantation | 1 | 2017 | 372 | 0.12 | Why? |
| Virus Replication | 7 | 2021 | 14331 | 0.12 | Why? |
| CRISPR-Cas Systems | 1 | 2021 | 1397 | 0.11 | Why? |
| beta-Lactamases | 1 | 2018 | 759 | 0.11 | Why? |
| Coronavirus 229E, Human | 4 | 2021 | 1241 | 0.11 | Why? |
| Whole Genome Sequencing | 2 | 2021 | 3239 | 0.11 | Why? |
| Workflow | 1 | 2021 | 2373 | 0.11 | Why? |
| Metagenomics | 1 | 2017 | 823 | 0.11 | Why? |
| Military Personnel | 1 | 2021 | 1097 | 0.11 | Why? |
| High-Throughput Nucleotide Sequencing | 2 | 2019 | 3633 | 0.10 | Why? |
| Open Reading Frames | 1 | 2016 | 1898 | 0.10 | Why? |
| Teaching | 1 | 2018 | 1208 | 0.10 | Why? |
| Lung Transplantation | 1 | 2020 | 1554 | 0.09 | Why? |
| Bacterial Proteins | 1 | 2018 | 1318 | 0.09 | Why? |
| Animals, Newborn | 1 | 2009 | 350 | 0.09 | Why? |
| Research Personnel | 1 | 2018 | 1037 | 0.09 | Why? |
| Milk | 1 | 2009 | 158 | 0.09 | Why? |
| Viral Envelope Proteins | 1 | 2020 | 3539 | 0.09 | Why? |
| Patient Isolation | 1 | 2021 | 3182 | 0.08 | Why? |
| Europe | 3 | 2021 | 12702 | 0.08 | Why? |
| Antibodies, Viral | 6 | 2022 | 51949 | 0.08 | Why? |
| Cell Line, Tumor | 2 | 2021 | 3608 | 0.08 | Why? |
| RNA, Viral | 8 | 2020 | 32276 | 0.08 | Why? |
| Humans | 30 | 2022 | 930598 | 0.08 | Why? |
| Dexamethasone | 1 | 2017 | 2055 | 0.08 | Why? |
| Pyrazines | 1 | 2017 | 1783 | 0.08 | Why? |
| Hemorrhagic Fever, Ebola | 1 | 2017 | 1475 | 0.08 | Why? |
| Zoonoses | 2 | 2018 | 3034 | 0.08 | Why? |
| Amides | 1 | 2017 | 1864 | 0.08 | Why? |
| Transcriptome | 1 | 2019 | 3466 | 0.07 | Why? |
| RNA-Directed DNA Polymerase | 1 | 2005 | 170 | 0.07 | Why? |
| Penicillamine | 1 | 2004 | 8 | 0.07 | Why? |
| Viruses | 1 | 2019 | 2238 | 0.07 | Why? |
| S-Nitroso-N-Acetylpenicillamine | 1 | 2004 | 19 | 0.07 | Why? |
| Nitric Oxide Donors | 1 | 2004 | 53 | 0.07 | Why? |
| Skin | 1 | 2016 | 2096 | 0.07 | Why? |
| Survival Analysis | 1 | 2017 | 7592 | 0.07 | Why? |
| Virus Shedding | 1 | 2020 | 5834 | 0.07 | Why? |
| Arvicolinae | 2 | 2017 | 49 | 0.07 | Why? |
| Signal Transduction | 1 | 2020 | 7207 | 0.07 | Why? |
| Coronavirus, Bovine | 1 | 2006 | 289 | 0.06 | Why? |
| Cell Survival | 1 | 2009 | 1581 | 0.06 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2009 | 13720 | 0.06 | Why? |
| Antiviral Agents | 4 | 2021 | 41703 | 0.06 | Why? |
| Chiroptera | 1 | 2017 | 3530 | 0.06 | Why? |
| Lung | 3 | 2020 | 31049 | 0.06 | Why? |
| Antibodies, Neutralizing | 4 | 2022 | 25288 | 0.06 | Why? |
| Niger | 1 | 2021 | 116 | 0.06 | Why? |
| X-Ray Microtomography | 1 | 2021 | 115 | 0.06 | Why? |
| Mali | 1 | 2021 | 181 | 0.06 | Why? |
| Host-Pathogen Interactions | 2 | 2021 | 11041 | 0.05 | Why? |
| Proviruses | 1 | 2021 | 82 | 0.05 | Why? |
| Afghanistan | 1 | 2021 | 224 | 0.05 | Why? |
| Immunocompromised Host | 1 | 2017 | 5150 | 0.05 | Why? |
| Democratic Republic of the Congo | 1 | 2021 | 500 | 0.05 | Why? |
| Immunosuppressive Agents | 1 | 2017 | 6331 | 0.05 | Why? |
| Cytokines | 1 | 2021 | 15010 | 0.05 | Why? |
| Phage Therapy | 1 | 2019 | 63 | 0.05 | Why? |
| Placenta | 1 | 2009 | 1531 | 0.05 | Why? |
| Anti-Inflammatory Agents | 1 | 2017 | 6153 | 0.04 | Why? |
| Mice, Inbred C57BL | 1 | 2009 | 5542 | 0.04 | Why? |
| Enterobacter cloacae | 1 | 2018 | 58 | 0.04 | Why? |
| Clinical Trials as Topic | 1 | 2017 | 7330 | 0.04 | Why? |
| Coinfection | 1 | 2018 | 6820 | 0.04 | Why? |
| Slovakia | 1 | 2017 | 135 | 0.04 | Why? |
| Guinea | 1 | 2017 | 228 | 0.04 | Why? |
| SARS Virus | 3 | 2005 | 13021 | 0.04 | Why? |
| Global Burden of Disease | 1 | 2020 | 531 | 0.04 | Why? |
| Czech Republic | 1 | 2017 | 307 | 0.04 | Why? |
| RNA, Complementary | 2 | 2005 | 11 | 0.04 | Why? |
| Respiratory Tract Infections | 2 | 2009 | 6817 | 0.04 | Why? |
| Vero Cells | 4 | 2005 | 14117 | 0.04 | Why? |
| Mice | 2 | 2020 | 21357 | 0.04 | Why? |
| Cameroon | 1 | 2017 | 464 | 0.04 | Why? |
| Molecular Epidemiology | 1 | 2021 | 1638 | 0.04 | Why? |
| Genotype | 2 | 2017 | 4697 | 0.04 | Why? |
| Academies and Institutes | 1 | 2018 | 539 | 0.04 | Why? |
| Medical Records | 1 | 2017 | 513 | 0.03 | Why? |
| Databases, Genetic | 1 | 2020 | 1127 | 0.03 | Why? |
| Virulence | 1 | 2021 | 2172 | 0.03 | Why? |
| Female | 9 | 2021 | 380317 | 0.03 | Why? |
| Furin | 1 | 2021 | 1054 | 0.03 | Why? |
| Swine | 2 | 2017 | 3352 | 0.03 | Why? |
| False Negative Reactions | 1 | 2020 | 1785 | 0.03 | Why? |
| Standard of Care | 1 | 2020 | 1297 | 0.03 | Why? |
| Drug Resistance, Microbial | 1 | 2018 | 419 | 0.03 | Why? |
| Feces | 2 | 2017 | 4235 | 0.03 | Why? |
| Peptide Hydrolases | 1 | 2021 | 1269 | 0.03 | Why? |
| Disease Outbreaks | 2 | 2018 | 27595 | 0.03 | Why? |
| Safety | 1 | 2020 | 1583 | 0.03 | Why? |
| Severe Acute Respiratory Syndrome | 3 | 2005 | 12361 | 0.03 | Why? |
| Gastroenteritis | 1 | 2017 | 489 | 0.03 | Why? |
| Virus Internalization | 2 | 2021 | 7921 | 0.03 | Why? |
| Confidentiality | 1 | 2017 | 581 | 0.03 | Why? |
| Klebsiella pneumoniae | 1 | 2018 | 658 | 0.03 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2021 | 2309 | 0.03 | Why? |
| Combined Modality Therapy | 1 | 2020 | 3395 | 0.03 | Why? |
| Temperature | 1 | 2021 | 2305 | 0.03 | Why? |
| Tissue Donors | 1 | 2020 | 1679 | 0.03 | Why? |
| Male | 7 | 2020 | 367725 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.03 | Why? |
| Gene Expression | 1 | 2021 | 3332 | 0.03 | Why? |
| Polymerase Chain Reaction | 1 | 2005 | 6740 | 0.03 | Why? |
| Informed Consent | 1 | 2017 | 890 | 0.02 | Why? |
| Cells, Cultured | 1 | 2021 | 5835 | 0.02 | Why? |
| Gene Expression Profiling | 1 | 2021 | 3788 | 0.02 | Why? |
| Antigens, Viral | 1 | 2006 | 6298 | 0.02 | Why? |
| Microbial Sensitivity Tests | 1 | 2018 | 2886 | 0.02 | Why? |
| Epithelial Cells | 1 | 2021 | 3508 | 0.02 | Why? |
| Gene Expression Regulation | 1 | 2021 | 4020 | 0.02 | Why? |
| Colitis, Ulcerative | 1 | 2017 | 1037 | 0.02 | Why? |
| Disease Reservoirs | 1 | 2017 | 1672 | 0.02 | Why? |
| Swine Diseases | 1 | 2017 | 1219 | 0.02 | Why? |
| Interferon Type I | 1 | 2020 | 2789 | 0.02 | Why? |
| Netherlands | 1 | 2016 | 3533 | 0.02 | Why? |
| Pregnancy | 1 | 2009 | 23879 | 0.02 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.02 | Why? |
| Immunity, Humoral | 1 | 2020 | 4849 | 0.02 | Why? |
| Coronavirus | 2 | 2005 | 18339 | 0.02 | Why? |
| Consensus Sequence | 1 | 2005 | 81 | 0.02 | Why? |
| Nitroprusside | 1 | 2004 | 18 | 0.02 | Why? |
| Serine Endopeptidases | 1 | 2021 | 4606 | 0.02 | Why? |
| Colony Count, Microbial | 1 | 2005 | 177 | 0.02 | Why? |
| Treatment Outcome | 2 | 2022 | 51732 | 0.02 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.02 | Why? |
| Molecular Diagnostic Techniques | 1 | 2020 | 4239 | 0.02 | Why? |
| Mortality | 1 | 2020 | 7132 | 0.02 | Why? |
| Communicable Diseases | 1 | 2018 | 2148 | 0.02 | Why? |
| Travel | 1 | 2021 | 7220 | 0.01 | Why? |
| Immunity, Innate | 1 | 2020 | 6570 | 0.01 | Why? |
| Antibodies, Monoclonal | 1 | 2021 | 8041 | 0.01 | Why? |
| Cytopathogenic Effect, Viral | 1 | 2004 | 635 | 0.01 | Why? |
| Species Specificity | 1 | 2006 | 1356 | 0.01 | Why? |
| Germany | 1 | 2017 | 9196 | 0.01 | Why? |
| Cattle | 1 | 2006 | 1336 | 0.01 | Why? |
| Inhibitory Concentration 50 | 1 | 2004 | 907 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 11367 | 0.01 | Why? |
| Research Design | 1 | 2017 | 5830 | 0.01 | Why? |
| Epidemics | 1 | 2021 | 6407 | 0.01 | Why? |
| DNA Primers | 1 | 2005 | 1170 | 0.01 | Why? |
| Hospitalization | 2 | 2022 | 54280 | 0.01 | Why? |
| Molecular Sequence Data | 1 | 2005 | 3198 | 0.01 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2021 | 8843 | 0.01 | Why? |
| Adult | 3 | 2022 | 244371 | 0.01 | Why? |
| Sequence Alignment | 1 | 2005 | 2109 | 0.01 | Why? |
| Cell Proliferation | 1 | 2005 | 1973 | 0.01 | Why? |
| Prospective Studies | 1 | 2022 | 43301 | 0.01 | Why? |
| Base Sequence | 1 | 2005 | 3581 | 0.01 | Why? |
| Anti-Bacterial Agents | 1 | 2018 | 10083 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.01 | Why? |
| Dose-Response Relationship, Drug | 1 | 2004 | 3776 | 0.01 | Why? |
| Communicable Disease Control | 2 | 2018 | 29620 | 0.01 | Why? |
| Sensitivity and Specificity | 2 | 2005 | 22971 | 0.01 | Why? |
| China | 1 | 2021 | 50654 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Infant | 2 | 2005 | 30274 | 0.01 | Why? |
| Antimalarials | 1 | 2004 | 2505 | 0.01 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.01 | Why? |
| Seasons | 1 | 2005 | 4071 | 0.01 | Why? |
| Child, Preschool | 2 | 2005 | 36283 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2005 | 11304 | 0.01 | Why? |
| Child | 2 | 2005 | 70012 | 0.00 | Why? |
| Aged | 1 | 2020 | 215776 | 0.00 | Why? |
| Pandemics | 2 | 2021 | 389249 | 0.00 | Why? |
| Incidence | 1 | 2005 | 25622 | 0.00 | Why? |
| Middle Aged | 1 | 2020 | 270681 | 0.00 | Why? |
| Time Factors | 1 | 2004 | 31397 | 0.00 | Why? |
| Adolescent | 1 | 2005 | 86841 | 0.00 | Why? |
Maes's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(236)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(259)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_